AIOBIO

Visualize. Diagnose. Prevent — with BLISS biofluorescence imaging

AIOBIO is headquartered in Seoul, South Korea, lists 11–50 employees, and has $5.8M in recorded funding across 2 rounds.

Headquarters
Seoul
Employees
11–50
Business Model
B2B
Total Funding
$5.8M
Last Round
$3.8M Corporate RoundJan 2019
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

AIOBIO is a Seoul-based healthcare technology company and the pioneering manufacturer of intraoral cameras utilizing Biofluorescence Technology for dental diagnostics. The company's flagship product line, BLISS (Biofluorescence Light Imaging System), uses fluorescence biomarkers to visualize hidden dental biofilm, early caries, and peri-implant disease that are invisible to conventional white-light examination. AIOBIO's technology enables dentists to practice preventive and precision dentistry — detecting disease before it progresses rather than treating it after the fact. The company's 5-Step Dentistry protocol integrates AI-driven imaging analysis, instant diagnostic feedback, and remote patient monitoring to streamline clinical workflows and improve diagnostic accuracy. AIOBIO holds regulatory approvals and has demonstrated its QBLISS and KBLISS camera platforms at major dental conferences globally. Founded by CEO Hongcheol Yoon, a prosthodontist PhD and president of the Yonsei University College of Dentistry.

Summary

AIOBIO is a Biotech company based in Seoul, South Korea. It lists 11–50 employees. It has raised $5.8M in total across 2 rounds, most recently a $3.8M Corporate Round in Jan 2019. Investors include IMM Investment, Korea Investment Partners and DSC Investment.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate Round2019 (est.)
$3.8M

Sign up to see all 2 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AIOBIO on Indexed.vc
<a href="https://indexed.vc/companies/aiobio"><img src="https://indexed.vc/api/badge/company/aiobio" alt="AIOBIO on Indexed.vc" width="260" height="76" /></a>